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Three bovine rotavirus strains belonging to two distinct serotype groups, serotype 6 (NCDV and B641) and
B223, distinct from the other six mammalian rotavirus serotypes but not yet assigned to a serotype group, were
compared with each other and with canine rotavirus (K9, serotype 3) by studying the properties of their cognate
polypeptide species VP4, VP6, and VP7. The three viruses showed distinct differences in the polyacrylamide gel
electrophoretic migration rates of protein species VP4 and VP7, with minor differences in VP6. Differences
were also observed among the migration patterns of genome segments 4, 6, and the 7-8-9 triplet, which encode
VP4, VP6, and VP7, respectively. Monoclonal antibodies (MAbs) to B223, which were directed against VP4 or
VP7, showed homologous specificity for neutralization and immunofluorescence (IF), although one MAb
reactive with VP4 also reacted by IF and by immunoprecipitation (IP) with all four viruses and weakly
neutralized B641 and K9. This MAb may react with the epitope responsible for the B223-induced one-way
neutralizing and protection response of calves against B641 observed in earlier studies. MAbs reactive with VP6
by IP showed enzyme-linked immunosorbent assay and IF reactivity with all three bovine viruses and the
canine virus. The two serotype 6 viruses could be distinguished by the two B641 MAbs, B641-N2b reacting by
neutralization and IF with both viruses and B641-N1 reacting with B641 and the serotype 3 canine rotavirus
but not with NCDV. One nonneutralizing B641 MAb reacted by IP and IF with VP7 of all four rotaviruses
examined, and one B223 MAb neutralized B223 and, to low titer, B641 and K9, although reacting by IP and
IF with all four viruses. Three MAb-resistant mutants were selected by passage of B223 in the presence of one
of three selected B223 MAbs at concentrations which only neutralized approximately 90% of the infectious
virions. The resulting mutants were 100% resistant to neutralization with their respective MAb but remained
neutralizable by the same selection of MAbs as the parent B223 virus.
The three bovine rotavirus isolates NCDV, B641, and
B223 can be subtyped according to their serotypic and
electrophoretic properties. NCDV and B641 have been
placed in the same serotype group, US bovine serotype 1
(26), or rotavirus serotype 6 (15), although they exhibit
minor antigenic differences. In contrast, B223 was placed in
a distinct serotype, US bovine rotavirus serotype 2 (26).
B223 is not neutralized by antisera used to serotype the other
six mammalian serotypes of rotavirus (H. F. Clark, Wistar
Institute, Philadelphia, Pa., personal communication; G. N.
Woode, unpublished data) but has not been assigned to a
rotavirus serotype group. All three viruses can be distin-
guished by their electropherotypes (26).
Studies of active immunity have demonstrated that a
complex antigenic relationship exists among the bovine
viruses. NCDV-vaccinated calves produced B641-neutral-
izing antibodies in their serum and intestines (coproantibod-
ies), but they were not protected against challenge with
B641. In contrast, calves vaccinated with B223, although a
different serotype, did develop low-titer heterologous neu-
tralizing antibodies to B641 and were protected against
challenge with B641. This was a one-way reaction, as calves
vaccinated with B641 neither developed neutralizing anti-
bodies to B223 nor were protected against challenge with
B223 virus (26, 27). Bridger and Oldham (3) also have
demonstrated a lack of correlation between serotype and
active immunity. However, most studies have shown that
active immunity to rotavirus infections in a number of
species is associated with the serotype specificities of rota-
* Corresponding author.
viruses, in these cases suggesting a specific role for the outer
capsid antigens of the viruses (reviewed in references 14 and
26).
VP4 and VP7 are outer capsid proteins encoded by ge-
nome segments 4 and 7, 8, or 9, respectively, depending on
the strain of rotavirus (16), and antibodies to either protein
neutralize rotavirus (17). Thus, these antigens are the deter-
minants of serotype specificity, passively acquired immu-
nity, and passive protection against challenge (18, 19, 21).
The results of homologous and heterologous challenge ex-
periments with NCDV, B641, and B223 show one-way
heterologous cross-protection among the three bovine rota-
viruses and suggest that the antigens'stimulating the produc-
tion of neutralizing antibodies are not always involved in the
development of active immunity. A recent report indicates
that cytolytic T lymphocytes from immunized animals rec-
ognize both homologous and heterologous rotavirus-infected
target cells in vitro (20). This suggests a possible role for
cytolytic T lymphocytes in heterologous protection from
rotavirus infection, although T-cell-deficient mice show nor-
mal recovery from experimental rotavirus infection (8).
Similarly, cytolytic T lymphocytes recognizing nonstruc-
tural antigens of heterotypic influenza A viruses have been
reported, and these cytolytic T lymphocytes appear to be
involved in heterologous protection (2).
To assist our investigations into the determinants of sero-
type specificity and active immunity in bovine rotaviruses,
we developed monoclonal antibodies (MAbs) against the
viral antigens VP4, VP6, and VP7 of B641 and B223, with the
expectation that common and strain-specific epitopes might
be identified among the three bovine rotavirus strains. In
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addition, the proteins of NCDV, B641, and B223 were
compared by polyacrylamide gel electrophoresis (PAGE).
Canine rotavirus (10), which is a serotype 3 rotavirus sharing
the common rotavirus antigen (VP6) with the bovine rotavi-
ruses (11), was included as a control.
MATERIALS AND METHODS
Rotavirus strains. The origins of the bovine rotaviruses
have been described previously (26). The canine rotavirus
(K9) was isolated (10) and cloned by plaque selection, and its
antigenic relationships were determined as a serotype 3
rotavirus (11, 15).
Reassortant viruses were constructed by crossing B223
and the 4F variant of SA11 (serotype 3) isolated by Pereira et
al. (22) in MA104 cells. The yield of virus was plated at high
dilution, well-isolated plaques were picked, and titers were
amplified by passage on MA104 cells. The parental origin of
genome segments in the progeny clones was determined by
electropherotype analysis on high-resolution gels as de-
scribed previously (12, 27). Progeny clones with desired
electropherotypes were sequentially plaque purified three
times, and the electropherotype was confirmed before use.
The B223/SA11-4F reassortants used in these studies reas-
sorted SA11-4F genome segment 4 (VP4), 6 (VP6), or 9
(VP7) in various combinations on a background of segments
derived from B223.
Genome RNA electropherotyping. The methods used for
genome RNA electropherotyping have been described pre-
viously (12, 27). Briefly, virus obtained from infected cul-
tures was ultrapelleted through 40% sucrose at 100,000 x g,
the RNA was extracted with phenol and chloroform, and
genome segments were analyzed by sodium dodecyl sulfate
(SDS)-PAGE in 7.5% gels.
Rotaviral polypeptides. The method of Ericson et al. (9)
was used for the intracellular radiolabeling of rotavirus
polypeptides with [35S]methionine and their extraction. The
polypeptides were analyzed by SDS-PAGE (5% stacking and
10% separating polyacrylamide gels under constant current).
MAb production. BALB/c mice were immunized with
either B223 or B641 which had been semipurified and pre-
pared with Freund complete adjuvant, followed 3 weeks
later with virus and Freund incomplete adjuvant. Immuni-
zations continued until the enzyme-linked immunosorbent
assay (ELISA) titer in serum reached 5 x 105 to 1 X 106 log
10 and the neutralization test (NT) titer was greater than
20,000. At 10 and 3 days prior to fusion, the mice were
inoculated with nonadjuvanted virus intravenously or intra-
peritoneally. The spleen cells (108 to 109 log 10) were isolated
and mixed with SP2/0 myeloma cells and mouse peritoneal
macrophages in the respective proportions of 300:100:1.
After centrifugation at 100 x g, 0.5 ml of 40% polyethylene
glycol was layered onto the cell pellet, gently stirred, and
incubated at 37°C for 1 min. Then 10 ml of selective
hybridoma medium (hypoxanthine-aminopterin-thymidine)
was added dropwise, followed by 10 ml quickly, and then the
suspension made up to 200 ml with hypoxanthine-aminop-
terin-thymidine medium. The cells were dispensed in 10
96-well microdilution plates.
Cell-free fluids from the hybridomas which originated
from preferably one colony were screened by NT, immuno-
fluorescence (IF), and ELISA at dilutions of 1:2, 1:5, and
1:10. NT and ELISA were performed with homologous
antigens. For IF, the homologous reaction was first tested,
and if it was positive, the hybridoma was retested with
heterologous (canine) rotavirus antigens.
The hybridoma cultures producing rotaviral MAbs were
cloned three times. All MAbs used in this study were
produced in tissue culture.
Antibody assays. The following assays were used to char-
acterize the MAbs and the B223 postinfection gnotobiotic
calf serum GC47 (26).
(i) NT. The NT has been described previously (26).
Approximately 500 immunofluorescent focus-forming units
(IFFU) of virus were incubated with antibody dilutions for 1
h at 37°C. The mixtures were inoculated into 96-well micro-
dilution plate cultures of BSC-1 cells and incubated at 37°C
for 18 to 20 h. The cultures were fixed and examined by IF.
Antibody titers were expressed as the highest dilution neu-
tralizing 50% or more of the IFFU.
(ii) IF. The indirect method of IF has been described
previously (27). Goat anti-mouse immunoglobulin G (heavy
and light chains) affinity-purified and fluorescein-labeled
antibodies (Kirkegaard and Perry Laboratories, Gaithers-
burg, Md.) were used for detection of MAb binding. For
identification of the MAb isotype, all the MAbs were tested
by IF with goat anti-mouse isotype-specific second antibod-
ies (Kirkegaard and Perry).
(iii) ELISA. The method used for ELISA has been de-
scribed previously (27), with the modification that goat
anti-mouse immunoglobulin G (heavy and light chains) affin-
ity-purified and peroxidase-labeled antibodies (Kirkegaard
and Perry) were used. A high titer (>108 IFFU/0.1 ml) of
infectious virus was prepared and used at a 1:200 or 1:400
dilution as the ELISA antigen.
(iv) IP. Immunoprecipitation (IP) was performed as de-
scribed by Holland et al. (13), with minor modifications.
Briefly, rotavirus-infected cultures without trypsin in the
medium were incubated for 5 h at 37°C, actinomycin D was
added to 5 ptg/ml, and after 1 h, the cells were pulse-labeled
with 4 jiCi of [35S]methionine per ml for a further hour. The
[35S]methionine-labeled soluble antigens were extracted
from infected cells by freeze-thawing and RIPA buffer and,
after high-molecular-weight complexes had been removed
by centrifugation, incubated with MAb or an appropriate
antiserum overnight at 4°C. Protein A-Sepharose CL-4B
beads (Pharmacia Fine Chemicals, Piscataway, N.J.) pre-
sensitized with rabbit anti-mouse or anti-bovine immuno-
globulins were added and incubated at 4°C for 1 h. The
antibody-antigen-protein A complex was centrifuged in a
microcentrifuge for 2 min and washed first with RIPA buffer
and then sequentially with 1.0 M NaCl (0.01 M Tris hydro-
chloride, 0.1% Nonidet P-40), with 0.1 M NaCl (1 mM
EDTA, 0.01 M Tris hydrochloride, 0.1% Nonidet P-40, 0.3%
SDS), and finally with 0.01 M Tris hydrochloride containing
0.1% Nonidet P-40. The pellet was suspended in sample
buffer (0.0625 M Tris hydrochloride, 10% glycerol, 2% SDS,
5.0% P-mercaptoethanol, pH 6.8), boiled for 3 min, and
pelleted in the microcentrifuge. The viral proteins in the
supernatant were analyzed by SDS-PAGE in a 0.75-mm 10%
separating gel with a 5% stacking gel run under constant
current. The gel was impregnated with scintillant (2,5-diphe-
nyloxazole, PPO), dried under vacuum, and exposed to
Kodak XAR-5 film at -70°C.
RESULTS
Electrophoretic characterization of bovine rotavirus ge-
nomes and polypeptides. The comparative electrophoretic
mobilities of the proteins of the three bovine viruses and the
canine virus control are shown in Fig. 1, and their respective
RNA electropherotypes are shown in Fig. 2. Distinct differ-
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FIG. 1. Comparison of rotavirus-infected cell polypeptide migra-
tion patterns by SDS-PAGE. K, 103.
ences were detected in the mobilities of VP4, VP6, and VP7.
Differences were also observed in the mobilities of RNA
segment 4 (encoding VP4), segment 6 (encoding VP6), and
segment 9 (encoding VP7). Electrophoretic polymorphism
were noted for other segments and polypeptide species, but
this study concentrated on the segments encoding the poly-
peptides VP4, VP6, and VP7.
Antigenic relationships among bovine rotavirus polypep-
tides. The results of comparative NT, IF, ELISA, and IP
assays for MAbs generated against B641 and B223 are given
in Table 1, and examples of IP are shown in Fig. 3.
Neutralizing MAbs are designated with an N suffix, and
nonneutralizing MAbs have an E suffix. All the MAbs were
of the immunoglobulin G isotype (data not shown).
The neutralizing MAbs were specific by NT for their
homologous bovine rotavirus, although one B223 MAb
10--
l1
FIG. 2. Comparison of viral RNA electrophoretic migration pat-
terns by SDS-PAGE.
(B223-N6) and one B641 MAb (B641-N1) showed lower-titer
cross-reactivity with B641 and canine rotavirus or with
canine rotavirus, respectively. The two serotype 6 viruses,
B641 and NCDV, apparently do not share all epitopes since
MAb B641-N1 only neutralized B641, whereas MAb B641-
N2b neutralized both viruses.
The IF test was positive with all the ELISA-reactive
(nonneutralizing) MAbs when tested against the three bovine
strains and the canine strain. Most of the ELISA-negative
(neutralizing) MAbs reacted in IF only with the homologous
virus, the exceptional MAbs being B223-N6, which cross-
reacted with all four viruses, B641-N1, which cross-reacted
with the canine virus, and B641-N2b, which cross-reacted
with NCDV. The IF test was found to be the most useful
antibody test for early screening of the hybridoma cultures
because the hybridomas were positive prior to the first
TABLE 1. Comparative properties of antirotavirus MAbs in NT, IF, ELISA, and IP tests
NT titer IF ELISA titer IP titer'
MAb
B223 B641 NCDV K9 B223 B641 NCDV K9 B223 B641 NCDV K9 B223 B641 NCDV K9
B223-E4 <4 <4 <4 <4 + + + + 4,096 8,192 16,384 4,096 6 6 6 6
B223-E8 <4 <4 <4 <4 + + + + 8,192 8,192 8,192 4,096 6 6 6 6
B223-N1 1,024 <4 <4 <4 + - - - <4 <4 <4 <4 4 - - -
B223-N3 2,048b <4 <4 <4 + - - - <4 <4 <4 <4 4 - - -
B223-N4 512b <4 <4 <4 + - - - <4 <4 <4 <4 4 - - -
B223-N6 1,024 4 <4 32 + + + + <4 <4 8 8 4 4 4 4
B223-N7 6,400 <4 4 <4 + - - - <4 <4 <4 <4 - NDC ND ND
B641-E2 <4 <4 <4 <4 + + + - 512 2,048 4,096 1,024 6 6 6 6
B641-E3 <4 <4 <4 <4 + + + + <4 64 512 16 7 7 7 7
B641-N1 <4 256 <4 128 - + - + <4 <4 <4 <4 - 4 - 4
B641-N2b <4 1,024 1,024 <4 - + + - <4 <4 <4 <4 - - - -
a IP of VP4, VP6, or VP7.
b Partial neutralization (70 to 90% IFFU) from 4-1024 (N3) and 4-256 (N4).
ND, Not done.
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FIG. 3. Example of IP (SDS-PAGE). Controls (not shown) included labeled proteins extracted from uninfected cultures with which the
MAbs did not react and IP of viral proteins VP4, VP6, and VP7 with the polyclonal serum GC47. IP of B223-infected cell polypeptides with
B223 MAbs: lanes 1 and 2, Ni; lanes 3 and 4, N3; lanes 6 and 7, N4; lanes 8 and 9, N6; lanes 11 and 12, E8. Lanes 5 and 10 are control
B223-infected cell polypeptides before IP treatment. Of each pair of lanes, the first represents the polypeptides remaining in the supernatant
after the IP procedure and the second represents the particular VP immunoprecipitated. For N6 (lane 9), a faint IP band was discernible for
VP4 which was confirmed by the reduction of the VP4 band in the supernatant (lane 8). Ni, N3, and N4 show IP with VP4 and VP5, and E8
immunoprecipitates with VP6. B223-E8 was run in the same gel in a different region, and for the purpose of this figure, lanes 11 and 12 were
moved in the photograph. K, 103.
cloning. This permitted the identification of MAbs which
only reacted with the homologous rotavirus, a good indica-
tion of a neutralizing MAb (Table 1). The ELISA was less
sensitive than the NT and IF tests for screening MAbs,
except for those reacting with the common rotavirus antigen
VP6, and was useful only in screening for nonneutralizing
MAbs. With only a single exception, B223-N6, the ELISA
was negative for neutralizing MAbs, and that exception was
positive only at very low titer. The nonneutralizing MAbs
cross-reacted in ELISA, IF, and IP, suggesting little type
specificity for ELISA-positive MAbs.
In IP assays, ELISA-positive (nonneutralizing) MAbs
precipitated the respective polypeptide species (VP6) across
serotypic boundaries, with the exception of B641-E3, which
immunoprecipitated VP7 of all four viruses. In contrast, the
ELISA-negative (neutralizing) MAbs were generally capable
of IP only with the homologous virus. The exceptions were
MAb B223-N6, which recognized an epitope on VP4 of all
four viruses examined, and MAb B641-N1, which also
recognized an epitope on VP4 of the canine virus. The
neutralizing MAbs B223-N7 and B641-N2b were particularly
interesting because they did not immunoprecipitate with
their respective polypeptides. To determine whether B223-
N7 was directed against VP4 or VP7, we used it in NTs with
reassortant viruses that segregated genome segments 4, 6,
and 9 of B223 with SA11-4F (Table 2). MAb B223-N7
neutralized only the reassortant virus that contained seg-
ment 9 from the B223 parent and failed to neutralize reas-
sortant clones containing segment 9 from the SA11-4F
parent or segment 4 from the B223 parent, indicating that the
6 7 8 910 11 12
_m m`A"
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TABLE 2. Neutralization of B223/SA11-4F reassortant viruses
Origin of segment MAb NT titer
Virus
4 6 9 B223-N7 B223-N1
B223 B B B 3,200 1,024
SA11-4F S S S <10 <10
Sy-159 S B B >1,000 <10
5y-149 B B S <10 1,000
5y-141 S B S <10 <10
6y-76 B B S <10 >100
a All segments not shown were derived from the B223 parent, except in the
SA11-4F parent, in which all segments were derived from SA11-4F. B and S
indicate that the segments were derived from either B223 or SA11-4F virus,
respectively.
neutralizing activity of the MAb was directed toward VP7 of
B223, the product of segment 9. Reassortants for B641,
NCDV, and canine rotaviruses were not available for deter-
mining whether B223-N7 or B641-N2b would react with their
respective VP7s.
The MAbs B223-N3 and B223-N4 were unusual in that
they left a relatively large nonneutralizable fraction of virus,
10% at a 1:4 dilution rising to 50% over 9 to 11 twofold
dilutions. The other MAbs behaved like polyclonal sera in
that over a range of three to four twofold dilutions, the
neutralized fraction fell from 100 to 0%. This observation
suggested that the B223 population used for the neutraliza-
tion tests was heterogeneous for the epitopes recognized by
B223-N3 and B223-N4. To investigate this possibility, we
incubated approximately 100 IFFU of B223 for 1 h with
B223-N1 (1:100 dilution), B223-N3 (1:40), or B223-N4 (1:40).
After incubation, cell cultures were inoculated and main-
tained with the same concentration of MAb in the medium.
At each passage, the virus was diluted to 100 IFFU and the
relevant MAb treatment was repeated. After passage 4, the
resulting viruses (MAb-resistant mutants B223N1, B223N3,
and B223N4) were passaged once without MAb treatment
and then tested for their susceptibility to neutralization with
a panel of MAbs and postinfection serum GC47 (Table 3).
Each mutant was no longer neutralizable with the selecting
MAb but remained neutralizable with all the other MAbs and
with GC47. This result indicated that MAb-resistant mutants
had been selected from the B223 population. The electro-
pherotypes of the MAb-resistant mutants were examined to
determine whether the selection was accompanied by
changes in the genomic RNAs as determined in high-resolu-
tion gels. All MAb-resistant mutants had electropherotypes
identical to that of the parental B223 virus (data not shown).
DISCUSSION
The results of the electrophoretic analyses of the polypep-
tides and genome RNAs of the bovine rotaviruses NCDV,
TABLE 3. NT titers of B223 and B223 MAb-resistant mutants
NT titer of indicated MAb or serum
Virus
B223-N1 B223-N3 B223-N4 B223-N7 GC47
B223 2,048 2,048 (4-1,024)a 512 (4-256)a 6,400 5,120
B223N1 <4 2,048 (4-1,024)a 512 (4-256)a >4,096 5,120
B223N3 2,048 <4 512 (4-256)a >4,096 5,120
B223N4 2,048 2,048 (4-1,024)- <4 >4,096 5,120
a A 10 to 30%o nonneutralizable fraction was obtained over the range of
dilutions indicated.
B641, and B223 confirmed the results of others (1) which
indicate that electrophoretic migration patterns, while useful
in epidemiological studies, do not predict serological rela-
tionships. Although differences in polypeptide and RNA
profiles were noted between serotypes (B223 versus B641
and NCDV), differences of similar magnitude were seen
within a serotype (B641 versus NCDV).
The neutralizing MAbs, on the other hand, provided
highly specific probes for distinguishing bovine serotypes
(B223 versus B641 and NCDV). The neutralizing MAbs
confirmed the serotype differences obtained with hyperim-
mune guinea pig antisera by neutralization (26). It was
interesting that one MAb, B223-N6, neutralized to low-titer
B641. This MAb may recognize a common neutralizing
epitope whose existence may explain the response of B223-
vaccinated calves who demonstrate a one-way heterologous
serum neutralization of B641 and protection against chal-
lenge with B641 (26, 27). In addition, the heterologous
neutralization by MAbs B223-N6 and B641-N1 of the canine
virus was interesting. Canine rotavirus belongs to serotype
3, and only at high concentrations of hyperimmune guinea
pig antisera has cross-neutralization between this serotype
and the bovine viruses been obtained (11). However, it has
not been determined whether these heterologous reacting
antibodies are directed against the same viral antigens (VP4
and VP7) as the homologous reacting antibodies. MAbs
generated against serotype 3 viruses did not cross-neutralize
a bovine virus of the serotype 6 group (5). Hyperimmunized
mice develop high-titer antibody responses which confer
passive protection both heterologously and homologously,
in contrast to orally infected mice, whose antibody re-
sponses are serotype specific (18). It appears that the hyper-
immunization response is qualitatively and quantitatively
different from the convalescent response and that this may
explain the presence of these heterologous reacting MAbs.
This conclusion is supported by the detection of an MAb
directed against VP4 of porcine OSU rotavirus (serotype 5)
which neutralized OSU, RRV (serotype 3), and UK bovine
(serotype 6) rotaviruses (19) and of MAbs cross-reactive
with VP4 of human rotaviruses of serotypes 1, 3, and 4 (23).
Presumably, there are weakly antigenic epitopes on VP4,
antibodies which may not be detected in a normal convales-
cent antibody response. It is possible that VP4 is responsible
for the one-way heterotypic neutralization and protection
responses seen with some rotaviruses. However, neutraliz-
ing MAbs cross-reactive with VP7s of different rotavirus
serotypes have also been reported (6, 23). In one of these
studies, high-titer ascites fluid MAbs were used, and the
differences between homologous and heterologous titers
varied from 2- to 300-fold (6). The VP4-reactive MAb
B223-N6, which showed weak cross-neutralization with
B641 and K9 but cross-reacted by IF and IP with all four
viruses, presumably represents common epitopes which are
only prominent in B223. The nonneutralizing and VP7-
reactive MAb B641-E3 reacted with all four rotaviruses by
IF and IP but not by ELISA. Evidence for shared epitopes
on VP7 of B223, B641, and NCDV had already been ob-
tained by Rosen (M.S. thesis, Iowa State University, Ames,
1986) using Western blotting (immunoblotting). As this
epitope is also on canine rotavirus, it is presumably encoded
in a conserved region of genome segment 9 and therefore has
no importance in in vitro neutralization reactions.
MAb B641-N2b, which was specific for the serotype 6
bovine rotaviruses B641 and NCDV, did not immunoprecip-
itate any of the viral proteins. In contrast, MAb B641-N1,
reactive with VP4, distinguished between the two viruses.
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Earlier data had shown that at least one B641-hyperim-
munized guinea pig antiserum had a 16-fold difference in NT
titer for the two viruses (26). Our data confirm this observa-
tion and suggest that either (i) B641 and NCDV do not share
a common gene 4 encoding VP4 or (ûi) B641 and NCDV
express different subsets of epitopes within the serotype 6
epitope set and thus represent different "monotypes" as
defined by Coulson (4). The cross-reaction of these two
viruses with most hyperimmune antisera and with polyclonal
calf antisera suggest that they share most epitopes and differ
only at this one epitope or at a small subset of epitopes. It is
possible that genome segment 4 and VP4 are responsible for
the lack of cross-protection between NCDV and B641 (26), if
the epitopes involved in protection were the same as the two
serotype 6 monotypes. On the other hand, completely dif-
ferent antigenic forms of VP4 could also be responsible for
the absence of cross-protection between B641 and NCDV.
To determine the basis for the antigenic relationship between
B641 and NCDV, reassortants among them and SA11 are
being prepared to identify shared genes and to determine
with which gene product, VP4 or VP7, MAb B641-N2b is
reactive.
The IF assay proved to be particularly useful for screening
MAbs, since it could be performed prior to the first cloning.
In addition, by determining the antigenic specificity of the
reaction, a prediction could be made whether a particular
MAb had neutralizing potential. In this study, the ELISA
was less useful than IF, NT, or IP for screening MAbs not
reactive with VP6.
MAbs B223-N3 and B223-N4 resulted in a large nonneu-
tralized fraction over a wide range of antibody dilutions,
leading us to speculate that the nonneutralized fraction
represented monotypic variants (4) within the parental B223
virus population. We were successful in selecting or enrich-
ing for these variants and were also able to isolate MAb-
resistant mutants to B223-N1, which showed a normal
neutralizing pattern. The rapid enrichment for the variants
that escaped neutralization with B223-N3 and B223-N4
suggested that these variants existed as a substantial portion
of the parental B223 population and are probably common in
nature. The homogeneity of the electropherotype of the
parental B223 population (26) and the absence of electro-
pherotype variation among these monotype variants serve to
emphasize that serological (monotypic) variation can occur
in the absence of other, more easily detectable changes and
that their demonstration requires the exquisite sensitivity of
MAbs. Antigenic variants or mutants similar to B223-N1
have been reported for human rotavirus VP3 (4, 25) and for
VP7 (6, 7, 24). However, we have not found a report of
MAbs behaving like B223-N3 and B223-N4. Whether mono-
type variation is important in nature may depend on the
particular epitope concerned. The variations reported here
probably are not important as they were specific to their
particular MAb and they did not escape neutralization by
postinfection serum. Another study has shown that similar
mutants escaped neutralization by hyperimmune sera but
not by postinfection sera (23).
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